Emany Sravan Kumar — SEC Form 4 filings
SEC reporting owner CIK 1897662. 16 Form 4 filings on record with FilingPulse; latest filed 2026-06-16.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-01-19 to 2026-06-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,684 shares, $100,216 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 17,295 shares, $215,451 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 6,294 shares @ $27.10 ($170,567) in Beam Therapeutics Inc., filed 2026-01-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | Chief Financial Officer | 4 | — | 1 leg · 6,294 sh · $170,567 | 4 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | SVP, COO and CFO | 7 | 1 leg · 10,684 sh · $100,216 | 1 leg · 11,001 sh · $44,884 | 7 |
| Assertio Holdings, Inc. (ASRT) | Director | 4 | — | — | 9 |
| Kyverna Therapeutics, Inc. (KYTX) | Director | 1 | — | — | 2 |
Form 4 filings — Emany Sravan Kumar
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-16 | 4 | Assertio Holdings, Inc. (ASRT) | Code (U): 23,855 @ $0 · Disposition to issuer (D): 1,753 (derivative) · Disposition to issuer (D): 5,415 (derivative) · Disposition to issuer (D): 5,415 (derivative) | EDGAR |
| 2026-05-06 | 4 | Assertio Holdings, Inc. (ASRT) | Grant/award (A): 4,851 @ $0 | EDGAR |
| 2026-04-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 31,750 @ $0 | EDGAR |
| 2026-02-26 | 4 | Kyverna Therapeutics, Inc. (KYTX) | Grant/award (A): 11,006 @ $0 · Grant/award (A): 42,945 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 63,500 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 6,294 @ $27.10 | EDGAR |
| 2025-05-09 | 4 | Assertio Holdings, Inc. (ASRT) | Grant/award (A): 53,750 @ $0 · Grant/award (A): 81,225 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 80,000 @ $0 · Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Sale (S): 11,001 @ $4.08 | EDGAR |
| 2024-05-28 | 4 | Assertio Holdings, Inc. (ASRT) | Grant/award (A): 53,750 @ $0 · Grant/award (A): 81,225 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Tax withholding (F): 18,280 @ $6.64 | EDGAR |
| 2024-03-12 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Option exercise (M): 37,120 @ $0 · Option exercise (M): 37,120 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Purchase (P): 10,684 @ $9.38 | EDGAR |
| 2024-02-14 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/award (A): 65,312 @ $0 · Grant/award (A): 32,656 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Tax withholding (F): 41,332 @ $14.90 | EDGAR |
| 2024-01-19 | 4 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/award (A): 85,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1897662 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →